180 related articles for article (PubMed ID: 20501952)
41. EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
Weidenfeld K; Barkan D
Front Oncol; 2018; 8():381. PubMed ID: 30258818
[TBL] [Abstract][Full Text] [Related]
42. Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.
Umansky V; Abschuetz O; Osen W; Ramacher M; Zhao F; Kato M; Schadendorf D
Cancer Res; 2008 Nov; 68(22):9451-8. PubMed ID: 19010920
[TBL] [Abstract][Full Text] [Related]
43. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C
Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000
[TBL] [Abstract][Full Text] [Related]
44. Choroidal melanoma. Enucleation or observation? A new approach.
Manschot WA; van Peperzeel HA
Arch Ophthalmol; 1980 Jan; 98(1):71-7. PubMed ID: 7352869
[TBL] [Abstract][Full Text] [Related]
45. Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis.
Doron H; Amer M; Ershaid N; Blazquez R; Shani O; Lahav TG; Cohen N; Adler O; Hakim Z; Pozzi S; Scomparin A; Cohen J; Yassin M; Monteran L; Grossman R; Tsarfaty G; Luxenburg C; Satchi-Fainaro R; Pukrop T; Erez N
Cell Rep; 2019 Aug; 28(7):1785-1798.e6. PubMed ID: 31412247
[TBL] [Abstract][Full Text] [Related]
46. Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response.
Nakamura Y; Fujisawa Y; Okiyama N; Watanabe R; Tanaka R; Ishitsuka Y; Tahara H; Fujimoto M
J Dermatol Sci; 2018 Apr; 90(1):46-51. PubMed ID: 29352630
[TBL] [Abstract][Full Text] [Related]
47. The natural course of cutaneous melanoma.
Leiter U; Meier F; Schittek B; Garbe C
J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923
[TBL] [Abstract][Full Text] [Related]
48. Lymphatic Vessels in Tumor Dissemination versus Immunotherapy.
Vaahtomeri K; Alitalo K
Cancer Res; 2020 Sep; 80(17):3463-3465. PubMed ID: 32605997
[TBL] [Abstract][Full Text] [Related]
49. Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.
Marcellini M; De Luca N; Riccioni T; Ciucci A; Orecchia A; Lacal PM; Ruffini F; Pesce M; Cianfarani F; Zambruno G; Orlandi A; Failla CM
Am J Pathol; 2006 Aug; 169(2):643-54. PubMed ID: 16877362
[TBL] [Abstract][Full Text] [Related]
50. Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.
Giordano M; Henin C; Maurizio J; Imbratta C; Bourdely P; Buferne M; Baitsch L; Vanhille L; Sieweke MH; Speiser DE; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
EMBO J; 2015 Aug; 34(15):2042-58. PubMed ID: 26139534
[TBL] [Abstract][Full Text] [Related]
51. Microvascular lymphatic density analysis in cutaneous regressive and nonregressive superficial spreading melanomas using the lymphatic marker D2-40.
da Costa HO; Sotto MN; Valente NY; da Silva LF; Sanches JA; da Silva AM; Festa Neto C
Am J Dermatopathol; 2011 Oct; 33(7):669-74. PubMed ID: 21915033
[TBL] [Abstract][Full Text] [Related]
52. Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells.
Touil Y; Segard P; Ostyn P; Begard S; Aspord C; El Machhour R; Masselot B; Vandomme J; Flamenco P; Idziorek T; Figeac M; Formstecher P; Quesnel B; Polakowska R
Sci Rep; 2016 Jul; 6():30405. PubMed ID: 27465291
[TBL] [Abstract][Full Text] [Related]
53. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Boukerche H; Benchaibi M; Berthier-Vergnes O; Lizard G; Bailly M; Bailly M; McGregor JL
Eur J Biochem; 1994 Mar; 220(2):485-91. PubMed ID: 8125107
[TBL] [Abstract][Full Text] [Related]
54. Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice.
Niederkorn JY
Invest Ophthalmol Vis Sci; 1984 Sep; 25(9):1080-6. PubMed ID: 6381375
[TBL] [Abstract][Full Text] [Related]
55. T lymphocytes restrain spontaneous metastases in permanent dormancy.
Romero I; Garrido C; Algarra I; Collado A; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Apr; 74(7):1958-68. PubMed ID: 24531750
[TBL] [Abstract][Full Text] [Related]
56. Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.
Le HK; Graham L; Miller CH; Kmieciak M; Manjili MH; Bear HD
Cancer Immunol Immunother; 2009 Oct; 58(10):1565-76. PubMed ID: 19198835
[TBL] [Abstract][Full Text] [Related]
57. PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8
Chen J; Song Y; Miao F; Chen G; Zhu Y; Wu N; Pang L; Chen Z; Chen X
Cancer Sci; 2021 Sep; 112(9):3437-3454. PubMed ID: 34152672
[TBL] [Abstract][Full Text] [Related]
58. Effect of artesunate on immune cells in ret-transgenic mouse melanoma model.
Ramacher M; Umansky V; Efferth T
Anticancer Drugs; 2009 Nov; 20(10):910-7. PubMed ID: 19745721
[TBL] [Abstract][Full Text] [Related]
59. Chemokine receptors and melanoma metastasis.
Murakami T; Cardones AR; Hwang ST
J Dermatol Sci; 2004 Nov; 36(2):71-8. PubMed ID: 15519136
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical analysis of the T-cell receptor beta-chain variable regions expressed by T lymphocytes infiltrating primary human melanoma.
Clemente C; Rao S; Lupetti R; Tragni G; Pisarra P; Bersani I; Parmiani G; Mihm MC; Sensi M
Lab Invest; 1998 May; 78(5):619-27. PubMed ID: 9605186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
